Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Borkowsky

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
The Journal of Infectious Diseases|May 24, 2000
Group-specific antibody levels surrounding invasive pneumococcal illness in children infected with human immunodeficiency virusJ C King, W Borkowsky, N Mahidhara, et al.
The Journal of Infectious Diseases|March 18, 2000
Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 CollaboratorsW Borkowsky, D Wara, T Fenton, et al.
The Journal of Infectious Diseases|May 1, 1996
Randomized study of the tolerance and efficacy of high- versus low-dose zidovudine in human immunodeficiency virus-infected children with mild to moderate symptoms (AIDS Clinical Trials Group 128). Pediatric AIDS Clinical Trials GroupM T Brady, N McGrath, P Brouwers, et al.
The Journal of Experimental Medicine|September 8, 1999
Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapyL Zhang, S R Lewin, M Markowitz, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 22, 1998
Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children. National Institutes of Health-sponsored Pediatric AIDS Clinical Trials Group (ACTG-218)J S Lambert, J McNamara, S L Katz, et al.
The Journal of Infectious Diseases|October 27, 2001
Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccineE J McFarland, W Borkowsky, T Fenton, et al.
Journal of Virus Eradication|February 20, 2016
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected childrenP Palma, C Foster, P Rojo, et al.
Journal of Virology|November 13, 1999
A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infantsL G Kostrikis, A U Neumann, B Thomson, et al.
The Journal of Infectious Diseases|November 9, 2000
Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials GroupL M Frenkel, E V Capparelli, W M Dankner, et al.
HIV Medicine|December 6, 2011
Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected childrenT I Miller, W Borkowsky, L A DiMeglio, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
The Journal of Infectious Diseases|May 24, 2000
Group-specific antibody levels surrounding invasive pneumococcal illness in children infected with human immunodeficiency virusJ C King, W Borkowsky, N Mahidhara, et al.
The Journal of Infectious Diseases|March 18, 2000
Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 CollaboratorsW Borkowsky, D Wara, T Fenton, et al.
The Journal of Infectious Diseases|May 1, 1996
Randomized study of the tolerance and efficacy of high- versus low-dose zidovudine in human immunodeficiency virus-infected children with mild to moderate symptoms (AIDS Clinical Trials Group 128). Pediatric AIDS Clinical Trials GroupM T Brady, N McGrath, P Brouwers, et al.
The Journal of Experimental Medicine|September 8, 1999
Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapyL Zhang, S R Lewin, M Markowitz, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 22, 1998
Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children. National Institutes of Health-sponsored Pediatric AIDS Clinical Trials Group (ACTG-218)J S Lambert, J McNamara, S L Katz, et al.
The Journal of Infectious Diseases|October 27, 2001
Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccineE J McFarland, W Borkowsky, T Fenton, et al.
Journal of Virus Eradication|February 20, 2016
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected childrenP Palma, C Foster, P Rojo, et al.
Journal of Virology|November 13, 1999
A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infantsL G Kostrikis, A U Neumann, B Thomson, et al.
The Journal of Infectious Diseases|November 9, 2000
Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials GroupL M Frenkel, E V Capparelli, W M Dankner, et al.
HIV Medicine|December 6, 2011
Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected childrenT I Miller, W Borkowsky, L A DiMeglio, et al.
Pageof 12